Pharmacogenetics of alcoholism: a clinical neuroscience perspective

Author： Ray Lara A   Courtney Kelly E   Bujarski Spencer   Squeglia Lindsay M  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.2, 2012-01, pp. : 129-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Naltrexone for the Treatment of Alcoholism: Clinical Findings, Mechanisms of Action, and Pharmacogenetics

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 13-22

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical pharmacology and pharmacogenetics of gemcitabine

By Wong Andrea   Soo Ross A.   Yong Wei-Peng   Innocenti Federico  

Drug Metabolism Reviews, Vol. 41, Iss. 2, 2009-05 ,pp. : 77-88

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics: global clinical markers

By Marsh Sharon  

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 371-373

Future Medicine

Access to resources Recommend Favorite

Clinical applications of pharmacogenetics in psychiatry

By Staddon Susan   Arranz Maria   Mancama Dalu   Mata I.   Kerwin Robert  

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 18-23

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of clinical response to risperidone

By LLerena Adrián   Berecz Roland   Peñas-LLedó Eva   Süveges Ágnes   Fariñas Humberto  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 177-194

Future Medicine

Access to resources Recommend Favorite